Xu L, Ye L, Huang Q
MedComm (2020). 2025; 6(3):e70132.
PMID: 40066223
PMC: 11892159.
DOI: 10.1002/mco2.70132.
Moss P
Nat Immunol. 2025; 26(3):331-332.
PMID: 40021899
DOI: 10.1038/s41590-025-02095-w.
Maison D, Tasissa H, Deitchman A, Peluso M, Deng Y, Miller F
Front Public Health. 2025; 13:1498445.
PMID: 39957982
PMC: 11826932.
DOI: 10.3389/fpubh.2025.1498445.
Ko K, Bae H, Park J, Lee J, Park S, Heo J
Nat Commun. 2024; 15(1):10368.
PMID: 39609429
PMC: 11604757.
DOI: 10.1038/s41467-024-54620-4.
Perdiguero B, Alvarez E, Marcos-Villar L, Sin L, Lopez-Bravo M, Valverde J
Vaccines (Basel). 2024; 12(11).
PMID: 39591118
PMC: 11598604.
DOI: 10.3390/vaccines12111213.
Maintenance and functional regulation of immune memory to COVID-19 vaccines in tissues.
Davis-Porada J, George A, Lam N, Caron D, Gray J, Huang J
Immunity. 2024; 57(12):2895-2913.e8.
PMID: 39510068
PMC: 11634668.
DOI: 10.1016/j.immuni.2024.10.003.
Distinct soluble immune checkpoint profiles characterize COVID-19 severity, mortality and SARS-CoV-2 variant infections.
Paranga T, Pavel-Tanasa M, Constantinescu D, Iftimi E, Plesca C, Miftode I
Front Immunol. 2024; 15:1464480.
PMID: 39376569
PMC: 11456479.
DOI: 10.3389/fimmu.2024.1464480.
CD4 and CD8 T cells are required to prevent SARS-CoV-2 persistence in the nasal compartment.
Kar M, Johnson K, Vanderheiden A, Elrod E, Floyd K, Geerling E
Sci Adv. 2024; 10(34):eadp2636.
PMID: 39178263
PMC: 11343035.
DOI: 10.1126/sciadv.adp2636.
Intranasal Multiepitope PD-L1-siRNA-Based Nanovaccine: The Next-Gen COVID-19 Immunotherapy.
Acurcio R, Kleiner R, Vaskovich-Koubi D, Carreira B, Liubomirski Y, Palma C
Adv Sci (Weinh). 2024; 11(40):e2404159.
PMID: 39116324
PMC: 11515909.
DOI: 10.1002/advs.202404159.
Sex-biased immunogenicity of a mucosal subunit vaccine against SARS-CoV-2 in mice.
Li J, Hsu K, Howe S, Hoang T, Xia Z, Berzofsky J
Front Immunol. 2024; 15:1386243.
PMID: 38835757
PMC: 11148259.
DOI: 10.3389/fimmu.2024.1386243.
Mucosal prime-boost immunization with live murine pneumonia virus-vectored SARS-CoV-2 vaccine is protective in macaques.
Kaiser J, Nelson C, Liu X, Park H, Matsuoka Y, Luongo C
Nat Commun. 2024; 15(1):3553.
PMID: 38670948
PMC: 11053155.
DOI: 10.1038/s41467-024-47784-6.
Microbiota and Immunity during Respiratory Infections: Lung and Gut Affair.
Marrella V, Nicchiotti F, Cassani B
Int J Mol Sci. 2024; 25(7).
PMID: 38612860
PMC: 11012346.
DOI: 10.3390/ijms25074051.
Intranasal boosting with RBD-HR protein vaccine elicits robust mucosal and systemic immune responses.
Chen L, Ren W, Lei H, Wang J, Que H, Wan D
Genes Dis. 2024; 11(4):101066.
PMID: 38550714
PMC: 10972810.
DOI: 10.1016/j.gendis.2023.06.035.
Seven-chain adaptive immune receptor repertoire analysis in rheumatoid arthritis reveals novel features associated with disease and clinically relevant phenotypes.
Aterido A, Lopez-Lasanta M, Blanco F, Juan-Mas A, Garcia-Vivar M, Erra A
Genome Biol. 2024; 25(1):68.
PMID: 38468286
PMC: 10926600.
DOI: 10.1186/s13059-024-03210-0.
NFκB and NLRP3/NLRC4 inflammasomes regulate differentiation, activation and functional properties of monocytes in response to distinct SARS-CoV-2 proteins.
Tsukalov I, Sanchez-Cerrillo I, Rajas O, Avalos E, Iturricastillo G, Esparcia L
Nat Commun. 2024; 15(1):2100.
PMID: 38453949
PMC: 10920883.
DOI: 10.1038/s41467-024-46322-8.
Tissue-Resident Memory T Cells in Allergy.
Long B, Zhou S, Gao Y, Fan K, Lai J, Yao C
Clin Rev Allergy Immunol. 2024; 66(1):64-75.
PMID: 38381299
DOI: 10.1007/s12016-024-08982-8.
Safety and Immunogenicity of the Convacell Recombinant N Protein COVID-19 Vaccine.
Rabdano S, Ruzanova E, Makarov D, Vertyachikh A, Teplykh V, Rudakov G
Vaccines (Basel). 2024; 12(1).
PMID: 38276672
PMC: 10821050.
DOI: 10.3390/vaccines12010100.
Post-pandemic memory T cell response to SARS-CoV-2 is durable, broadly targeted, and cross-reactive to the hypermutated BA.2.86 variant.
Nesamari R, Omondi M, Baguma R, Hoft M, Ngomti A, Nkayi A
Cell Host Microbe. 2024; 32(2):162-169.e3.
PMID: 38211583
PMC: 10901529.
DOI: 10.1016/j.chom.2023.12.003.
Human organoids-on-chips for biomedical research and applications.
Wang H, Ning X, Zhao F, Zhao H, Li D
Theranostics. 2024; 14(2):788-818.
PMID: 38169573
PMC: 10758054.
DOI: 10.7150/thno.90492.
Persistence of T-Cell Immunity Responses against SARS-CoV-2 for over 12 Months Post COVID-19 Infection in Unvaccinated Individuals with No Detectable IgG Antibodies.
Pitiriga V, Papamentzelopoulou M, Konstantinakou K, Vasileiou I, Sakellariou K, Spyrou N
Vaccines (Basel). 2023; 11(12).
PMID: 38140169
PMC: 10747023.
DOI: 10.3390/vaccines11121764.